Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Julie Rich Ingelfinger, M.D.

TitleProfessor of Pediatrics
InstitutionMassachusetts General Hospital
DepartmentPediatrics
AddressMassachusetts General Hospital
Ped Nephrology Unit, Yawkey 6C
55 Fruit St
Boston MA 02114
Phone617/726-2908
Fax617/726-3044

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ingelfinger JR. Past mortality risk and survival: living well and growing up. Am J Kidney Dis. 2013 Nov; 62(5):880-2.
    View in: PubMed
  2. Ingelfinger JR, Marsden PA. Estimated GFR and risk of death--is cystatin C useful? N Engl J Med. 2013 Sep 5; 369(10):974-5.
    View in: PubMed
  3. Ingelfinger JR, Alexander SI. One step closer to "rejectostix". N Engl J Med. 2013 Jul 4; 369(1):84-5.
    View in: PubMed
  4. Grabowski EF, Kushak RI, Liu B, Ingelfinger JR. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium. Thromb Res. 2013 Jun; 131(6):521-8.
    View in: PubMed
  5. Abdo S, Lo CS, Chenier I, Shamsuyarova A, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia. 2013 Jul; 56(7):1649-60.
    View in: PubMed
  6. Shi Y, Lo CS, Chenier I, Maachi H, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice. Am J Physiol Renal Physiol. 2013 Jun; 304(11):F1335-46.
    View in: PubMed
  7. Chang SY, Chen YW, Zhao XP, Chenier I, Tran S, Sauvé A, Ingelfinger JR, Zhang SL. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes. 2012 Oct; 61(10):2565-74.
    View in: PubMed
  8. Lo CS, Chang SY, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes. 2012 Oct; 61(10):2597-608.
    View in: PubMed
  9. Ingelfinger JR. Selective, isolated proximal tubular angiotensinogen overexpression and salt-sensitive hypertension. Am J Hypertens. 2012 Jun; 25(6):628.
    View in: PubMed
  10. Ingelfinger JR, Nuyt AM. Impact of fetal programming, birth weight, and infant feeding on later hypertension. J Clin Hypertens (Greenwich). 2012 Jun; 14(6):365-71.
    View in: PubMed
  11. Satou R, Miyata K, Gonzalez-Villalobos RA, Ingelfinger JR, Navar LG, Kobori H. Interferon-? biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J. 2012 May; 26(5):1821-30.
    View in: PubMed
  12. Lau GJ, Godin N, Maachi H, Lo CS, Wu SJ, Zhu JX, Brezniceanu ML, Chénier I, Fragasso-Marquis J, Lattouf JB, Ethier J, Filep JG, Ingelfinger JR, Nair V, Kretzler M, Cohen CD, Zhang SL, Chan JS. Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice. Diabetes. 2012 Feb; 61(2):474-84.
    View in: PubMed
  13. Lo CS, Liu F, Shi Y, Maachi H, Chenier I, Godin N, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am J Physiol Renal Physiol. 2012 Apr 1; 302(7):F840-52.
    View in: PubMed
  14. Ingelfinger JR. Bariatric surgery in adolescents. N Engl J Med. 2011 Oct 13; 365(15):1365-7.
    View in: PubMed
  15. Lamas DJ, Ingelfinger JR, Rosenbaum LS. Clinical decisions. Treatment of a 6-year-old girl with vesicoureteral reflux--polling results. N Engl J Med. 2011 Aug 25; 365(8):e17.
    View in: PubMed
  16. Ingelfinger JR. MYO1E, focal segmental glomerulosclerosis, and the cytoskeleton. N Engl J Med. 2011 Jul 28; 365(4):368-9.
    View in: PubMed
  17. Ingelfinger JR, Drazen JM. Patient organizations and research on rare diseases. N Engl J Med. 2011 Apr 28; 364(17):1670-1.
    View in: PubMed
  18. Ingelfinger JR. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes. N Engl J Med. 2011 Mar 10; 364(10):970-1.
    View in: PubMed
  19. Chen YW, Chenier I, Chang SY, Tran S, Ingelfinger JR, Zhang SL. High glucose promotes nascent nephron apoptosis via NF-kappaB and p53 pathways. Am J Physiol Renal Physiol. 2011 Jan; 300(1):F147-56.
    View in: PubMed
  20. Ingelfinger JR. Hypertension control in African-American patients with chronic kidney disease. N Engl J Med. 2010 Sep 2; 363(10):974-6.
    View in: PubMed
  21. Daouk GH, Ingelfinger JR. Recent advances in the pathogenesis of hypertension in children. J Med Liban. 2010 Jul-Sep; 58(3):137-41.
    View in: PubMed
  22. Brezniceanu ML, Lau CJ, Godin N, Chénier I, Duclos A, Ethier J, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol. 2010 Jun; 21(6):943-54.
    View in: PubMed
  23. Godin N, Liu F, Lau GJ, Brezniceanu ML, Chénier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int. 2010 Jun; 77(12):1086-97.
    View in: PubMed
  24. Ingelfinger JR. Blood-pressure control and delay in progression of kidney disease in children. N Engl J Med. 2009 Oct 22; 361(17):1701-3.
    View in: PubMed
  25. Bouley R, Palomino Z, Tang SS, Nunes P, Kobori H, Lu HA, Shum WW, Sabolic I, Brown D, Ingelfinger JR, Jung FF. Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression. Am J Physiol Renal Physiol. 2009 Dec; 297(6):F1575-86.
    View in: PubMed
  26. Dötsch J, Plank C, Amann K, Ingelfinger J. The implications of fetal programming of glomerular number and renal function. J Mol Med (Berl). 2009 Sep; 87(9):841-8.
    View in: PubMed
  27. Abitbol CL, Ingelfinger JR. Nephron mass and cardiovascular and renal disease risks. Semin Nephrol. 2009 Jul; 29(4):445-54.
    View in: PubMed
  28. Kawakami T, Inagi R, Takano H, Sato S, Ingelfinger JR, Fujita T, Nangaku M. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol Dial Transplant. 2009 Sep; 24(9):2665-72.
    View in: PubMed
  29. Kumagai T, Nangaku M, Kojima I, Nagai R, Ingelfinger JR, Miyata T, Fujita T, Inagi R. Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol. 2009 Apr; 296(4):F912-21.
    View in: PubMed
  30. Langman CB, Alon U, Ingelfinger J, Englund M, Saland JM, Somers MJ, Stapleton FB, Sibú NO, Cochat P, Wong W, Eke FU, Satlin L, Salusky I. A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infants. Pediatr Nephrol. 2009 Jul; 24(7):1263-6.
    View in: PubMed
  31. Ingelfinger JR. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens. 2009 Jan; 18(1):79-84.
    View in: PubMed
  32. Ingelfinger JR. Melamine and the global implications of food contamination. N Engl J Med. 2008 Dec 25; 359(26):2745-8.
    View in: PubMed
  33. Liu F, Wei CC, Wu SJ, Chenier I, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int. 2009 Jan; 75(2):156-66.
    View in: PubMed
  34. Chen YW, Tran S, Chenier I, Chan JS, Ingelfinger JR, Inagami T, Zhang SL. Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis. Pediatr Nephrol. 2008 Oct; 23(10):1769-77.
    View in: PubMed
  35. Ingelfinger JR. Aliskiren and dual therapy in type 2 diabetes mellitus. N Engl J Med. 2008 Jun 5; 358(23):2503-5.
    View in: PubMed
  36. Ingelfinger JR. Disparities in renal endowment: causes and consequences. Adv Chronic Kidney Dis. 2008 Apr; 15(2):107-14.
    View in: PubMed
  37. Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, Hébert MJ, Ingelfinger JR, Zhang SL. Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol. 2008 May; 19(5):943-52.
    View in: PubMed
  38. Halperin F, Ingelfinger JR, McMahon GT. Clinical decisions. Management of type 2 diabetes--polling results. N Engl J Med. 2008 Feb 14; 358(7):e8.
    View in: PubMed
  39. Ingelfinger JR. Weight for gestational age as a baseline predictor of kidney function in adulthood. Am J Kidney Dis. 2008 Jan; 51(1):1-4.
    View in: PubMed
  40. Katavetin P, Inagi R, Miyata T, Tanaka T, Sassa R, Ingelfinger JR, Fujita T, Nangaku M. Albumin suppresses vascular endothelial growth factor via alteration of hypoxia-inducible factor/hypoxia-responsive element pathway. Biochem Biophys Res Commun. 2008 Mar 7; 367(2):305-10.
    View in: PubMed
  41. Liu F, Brezniceanu ML, Wei CC, Chénier I, Sachetelli S, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol. 2008 Feb; 19(2):269-80.
    View in: PubMed
  42. Nestoridi E, Kushak RI, Tsukurov O, Grabowski EF, Ingelfinger JR. Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression. Pediatr Nephrol. 2008 Feb; 23(2):221-31.
    View in: PubMed
  43. Brezniceanu ML, Liu F, Wei CC, Chénier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes. 2008 Feb; 57(2):451-9.
    View in: PubMed
  44. Zhang SL, Chen YW, Tran S, Chenier I, Hébert MJ, Ingelfinger JR. Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol. 2007 Jul; 18(7):2105-15.
    View in: PubMed
  45. Ingelfinger JR. Prematurity and the legacy of intrauterine stress. N Engl J Med. 2007 May 17; 356(20):2093-5.
    View in: PubMed
  46. Ingelfinger JR, Remuzzi G. Target haemoglobin concentrations in chronic kidney disease. Lancet. 2007 May 5; 369(9572):1515; author reply 1516-7.
    View in: PubMed
  47. Ingelfinger JR. Through the looking glass: anemia guidelines, vested interests, and distortions. Clin J Am Soc Nephrol. 2007 May; 2(3):415-7.
    View in: PubMed
  48. Zhang SL, Chen YW, Tran S, Liu F, Nestoridi E, Hébert MJ, Ingelfinger JR. Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol. 2007 Jun; 22(6):813-24.
    View in: PubMed
  49. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JS. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. 2007 May; 71(9):912-23.
    View in: PubMed
  50. Remuzzi G, Ingelfinger JR. Correction of anemia--payoffs and problems. N Engl J Med. 2006 Nov 16; 355(20):2144-6.
    View in: PubMed
  51. Ingelfinger JR. ACE2: a new target for prevention of diabetic nephropathy? J Am Soc Nephrol. 2006 Nov; 17(11):2957-9.
    View in: PubMed
  52. Ingelfinger JR. The molecular basis of pediatric hypertension. Pediatr Clin North Am. 2006 Oct; 53(5):1011-28, x-xi.
    View in: PubMed
  53. Chen YW, Liu F, Tran S, Zhu Y, Hébert MJ, Ingelfinger JR, Zhang SL. Reactive oxygen species and nuclear factor-kappa B pathway mediate high glucose-induced Pax-2 gene expression in mouse embryonic mesenchymal epithelial cells and kidney explants. Kidney Int. 2006 Nov; 70(9):1607-15.
    View in: PubMed
  54. Ingelfinger JR, Solomon CG. Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance--is there still hope? N Engl J Med. 2006 Oct 12; 355(15):1608-10.
    View in: PubMed
  55. Ohse T, Inagi R, Tanaka T, Ota T, Miyata T, Kojima I, Ingelfinger JR, Ogawa S, Fujita T, Nangaku M. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int. 2006 Oct; 70(8):1447-55.
    View in: PubMed
  56. Gunay-Aygun M, Avner ED, Bacallao RL, Choyke PL, Flynn JT, Germino GG, Guay-Woodford L, Harris P, Heller T, Ingelfinger J, Kaskel F, Kleta R, LaRusso NF, Mohan P, Pazour GJ, Shneider BL, Torres VE, Wilson P, Zak C, Zhou J, Gahl WA. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr. 2006 Aug; 149(2):159-64.
    View in: PubMed
  57. Hamel MB, Ingelfinger JR, Phimister E, Solomon CG. Women in academic medicine--progress and challenges. N Engl J Med. 2006 Jul 20; 355(3):310-2.
    View in: PubMed
  58. Wei CC, Zhang SL, Chen YW, Guo DF, Ingelfinger JR, Bomsztyk K, Chan JS. Heterogeneous nuclear ribonucleoprotein K modulates angiotensinogen gene expression in kidney cells. J Biol Chem. 2006 Sep 1; 281(35):25344-55.
    View in: PubMed
  59. Brezniceanu ML, Wei CC, Zhang SL, Hsieh TJ, Guo DF, Hébert MJ, Ingelfinger JR, Filep JG, Chan JS. Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells. Kidney Int. 2006 Jun; 69(11):1977-85.
    View in: PubMed
  60. Harmon W, Meyers K, Ingelfinger J, McDonald R, McIntosh M, Ho M, Spaneas L, Palmer JA, Hawk M, Geehan C, Tinckam K, Hancock WW, Sayegh MH. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol. 2006 Jun; 17(6):1735-45.
    View in: PubMed
  61. Katavetin P, Miyata T, Inagi R, Tanaka T, Sassa R, Ingelfinger JR, Fujita T, Nangaku M. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol. 2006 May; 17(5):1405-13.
    View in: PubMed
  62. Hsieh TJ, Chen R, Zhang SL, Liu F, Brezniceanu ML, Whiteside CI, Fantus IG, Ingelfinger JR, Hamet P, Chan JS. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Kidney Int. 2006 Mar; 69(6):1005-15.
    View in: PubMed
  63. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Guo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int. 2006 Mar; 69(6):1016-23.
    View in: PubMed
  64. Tanaka T, Kojima I, Ohse T, Ingelfinger JR, Adler S, Fujita T, Nangaku M. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest. 2005 Oct; 85(10):1292-307.
    View in: PubMed
  65. Ingelfinger JR, Schwartz RS. Immunosuppression--the promise of specificity. N Engl J Med. 2005 Aug 25; 353(8):836-9.
    View in: PubMed
  66. Ingelfinger JR. Risks and benefits to the living donor. N Engl J Med. 2005 Aug 4; 353(5):447-9.
    View in: PubMed
  67. Ingelfinger JR, Schnaper HW. Renal endowment: developmental origins of adult disease. J Am Soc Nephrol. 2005 Sep; 16(9):2533-6.
    View in: PubMed
  68. Woods LL, Ingelfinger JR, Rasch R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol. 2005 Oct; 289(4):R1131-6.
    View in: PubMed
  69. Tanaka T, Kojima I, Ohse T, Inagi R, Miyata T, Ingelfinger JR, Fujita T, Nangaku M. Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity. Am J Physiol Renal Physiol. 2005 Nov; 289(5):F1123-33.
    View in: PubMed
  70. Nestoridi E, Kushak RI, Duguerre D, Grabowski EF, Ingelfinger JR. Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int. 2005 Jun; 67(6):2254-66.
    View in: PubMed
  71. Kohane DS, Ingelfinger JR, Nimkin K, Wu CL. Case records of the Massachusetts General Hospital. Case 16-2005. A nine-year-old girl with headaches and hypertension. N Engl J Med. 2005 May 26; 352(21):2223-31.
    View in: PubMed
  72. Kushak RI, Nestoridi E, Lambert J, Selig MK, Ingelfinger JR, Grabowski EF. Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res. 2005; 116(5):409-19.
    View in: PubMed
  73. Nestoridi E, Tsukurov O, Kushak RI, Ingelfinger JR, Grabowski EF. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome. J Thromb Haemost. 2005 Apr; 3(4):752-62.
    View in: PubMed
  74. Ingelfinger JR. Agonistic autoantibodies and rejection of renal allografts. N Engl J Med. 2005 Feb 10; 352(6):617-9.
    View in: PubMed
  75. Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA. First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future. Pediatr Nephrol. 2005 Apr; 20(4):452-4.
    View in: PubMed
  76. Wei CC, Guo DF, Zhang SL, Ingelfinger JR, Chan JS. Heterogenous nuclear ribonucleoprotein F modulates angiotensinogen gene expression in rat kidney proximal tubular cells. J Am Soc Nephrol. 2005 Mar; 16(3):616-28.
    View in: PubMed
  77. Hsieh TJ, Fustier P, Wei CC, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol. 2004 Dec; 183(3):535-50.
    View in: PubMed
  78. Zhang SL, Guo J, Moini B, Ingelfinger JR. Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int. 2004 Dec; 66(6):2181-92.
    View in: PubMed
  79. Tanaka T, Nangaku M, Miyata T, Inagi R, Ohse T, Ingelfinger JR, Fujita T. Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. J Am Soc Nephrol. 2004 Sep; 15(9):2320-33.
    View in: PubMed
  80. Ingelfinger JR. Pathogenesis of perinatal programming. Curr Opin Nephrol Hypertens. 2004 Jul; 13(4):459-64.
    View in: PubMed
  81. Zhang SL, Moini B, Ingelfinger JR. Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. J Am Soc Nephrol. 2004 Jun; 15(6):1452-65.
    View in: PubMed
  82. Ingelfinger JR. Pediatric antecedents of adult cardiovascular disease--awareness and intervention. N Engl J Med. 2004 May 20; 350(21):2123-6.
    View in: PubMed
  83. Ingelfinger JR, Drazen JM. Registry research and medical privacy. N Engl J Med. 2004 Apr 1; 350(14):1452-3.
    View in: PubMed
  84. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 2004 Mar; 65(3):871-80.
    View in: PubMed
  85. Guo DF, Tardif V, Ghelima K, Chan JS, Ingelfinger JR, Chen X, Chenier I. A novel angiotensin II type 1 receptor-associated protein induces cellular hypertrophy in rat vascular smooth muscle and renal proximal tubular cells. J Biol Chem. 2004 May 14; 279(20):21109-20.
    View in: PubMed
  86. Ingelfinger JR. Forestalling fibrosis. N Engl J Med. 2003 Dec 4; 349(23):2265-6.
    View in: PubMed
  87. Drazen JM, Ingelfinger JR. Grants, politics, and the NIH. N Engl J Med. 2003 Dec 4; 349(23):2259-61.
    View in: PubMed
  88. Drazen JM, Ingelfinger JR, Curfman GD. Removal of expression of concern: Schiffl H, et Al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10. N Engl J Med. 2003 Nov 13; 349(20):1965.
    View in: PubMed
  89. Tanaka T, Hanafusa N, Ingelfinger JR, Ohse T, Fujita T, Nangaku M. Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun. 2003 Sep 12; 309(1):222-31.
    View in: PubMed
  90. Hsieh TJ, Fustier P, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology. 2003 Oct; 144(10):4338-49.
    View in: PubMed
  91. Ingelfinger JR. Congenital ureteral obstruction: new technology, new targets. Kidney Int. 2003 Jul; 64(1):361-2.
    View in: PubMed
  92. Drazen JM, Ingelfinger JR, Curfman GD. Expression of concern: Schiffl H, et Al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10. N Engl J Med. 2003 May 22; 348(21):2137.
    View in: PubMed
  93. Kanakiriya SK, Croatt AJ, Haggard JJ, Ingelfinger JR, Tang SS, Alam J, Nath KA. Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Am J Physiol Renal Physiol. 2003 Mar; 284(3):F546-54.
    View in: PubMed
  94. Ingelfinger JR. Is microanatomy destiny? N Engl J Med. 2003 Jan 9; 348(2):99-100.
    View in: PubMed
  95. Kiley SC, Thornhill BA, Tang SS, Ingelfinger JR, Chevalier RL. Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int. 2003 Jan; 63(1):33-42.
    View in: PubMed
  96. Zhang SL, Chen X, Wei CC, Filep JG, Tang SS, Ingelfinger JR, Chan JS. Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. Endocrinology. 2002 Dec; 143(12):4627-35.
    View in: PubMed
  97. Alam J, Killeen E, Gong P, Naquin R, Hu B, Stewart D, Ingelfinger JR, Nath KA. Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am J Physiol Renal Physiol. 2003 Apr; 284(4):F743-52.
    View in: PubMed
  98. Ingelfinger JR. Ambulatory blood-pressure monitoring as a predictive tool. N Engl J Med. 2002 Sep 12; 347(11):778-9.
    View in: PubMed
  99. Ingelfinger JR. Nephrogenic adenomas as renal tubular outposts. N Engl J Med. 2002 Aug 29; 347(9):684-6.
    View in: PubMed
  100. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology. 2002 Aug; 143(8):2975-85.
    View in: PubMed
  101. Yoshida T, Kurella M, Beato F, Min H, Ingelfinger JR, Stears RL, Swinford RD, Gullans SR, Tang SS. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int. 2002 May; 61(5):1646-54.
    View in: PubMed
  102. Nehal US, Ingelfinger JR. Pediatric hypertension: recent literature. Curr Opin Pediatr. 2002 Apr; 14(2):189-96.
    View in: PubMed
  103. Yoshida T, Tang SS, Hsiao LL, Jensen RV, Ingelfinger JR, Gullans SR. Global analysis of gene expression in renal ischemia-reperfusion in the mouse. Biochem Biophys Res Commun. 2002 Mar 8; 291(4):787-94.
    View in: PubMed
  104. Ingelfinger JR, Woods LL. Perinatal programming, renal development, and adult renal function. Am J Hypertens. 2002 Feb; 15(2 Pt 2):46S-49S.
    View in: PubMed
  105. Hyperglycemia induces insulin resistance on angiotensinogen gene expression in diabetic rat kidney proximal tubular cells. J Endocrinol. 2002 Feb; 172(2):333-44.
    View in: PubMed
  106. Zhang SL, To C, Chen X, Filep JG, Tang SS, Ingelfinger JR, Chan JS. Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol. 2002 Feb; 13(2):302-12.
    View in: PubMed
  107. Swinford RD, Pascual M, Diamant D, Tang SS, Ingelfinger JR. Rapamycin increases transforming growth factor-beta mRNA expression in immortalized rat proximal renal tubular cells. Transplantation. 2002 Jan 27; 73(2):319-20.
    View in: PubMed
  108. Ingelfinger JR. Diet and kidney stones. N Engl J Med. 2002 Jan 10; 346(2):74-6.
    View in: PubMed
  109. Ishizaka N, Aizawa T, Ohno M, Usui Si S, Mori I, Tang SS, Ingelfinger JR, Kimura S, Nagai R. Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension. 2002 Jan; 39(1):122-8.
    View in: PubMed
  110. Ishizaka N, Aizawa T, Yamazaki I, Usui S, Mori I, Kurokawa K, Tang SS, Ingelfinger JR, Ohno M, Nagai R. Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest. 2002 Jan; 82(1):87-96.
    View in: PubMed
  111. Chen X, Zhang SL, Pang L, Filep JG, Tang SS, Ingelfinger JR, Chan JS. Characterization of a putative insulin-responsive element and its binding protein(s) in rat angiotensinogen gene promoter: regulation by glucose and insulin. Endocrinology. 2001 Jun; 142(6):2577-85.
    View in: PubMed
  112. Dluhy RG, Anderson B, Harlin B, Ingelfinger J, Lifton R. Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J Pediatr. 2001 May; 138(5):715-20.
    View in: PubMed
  113. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res. 2001 Apr; 49(4):460-7.
    View in: PubMed
  114. Zhang SL, To C, Chen X, Filep JG, Tang SS, Ingelfinger JR, Carrière S, Chan JS. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells. Exp Nephrol. 2001 Mar-Apr; 9(2):109-17.
    View in: PubMed
  115. Zhang SL, Tang SS, Chen X, Filep JG, Ingelfinger JR, Chan JS. High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells. Endocrinology. 2000 Dec; 141(12):4637-46.
    View in: PubMed
  116. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000 Jun; 105(6):1242-9.
    View in: PubMed
  117. Grabowski EF, Carter CA, Tsukurov O, Conroy N, Hsu CY, Abbott WM, Ingelfinger JR, Orkin RW. Comparison of human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function. J Pediatr Hematol Oncol. 2000 May-Jun; 22(3):266-8.
    View in: PubMed
  118. Aizawa T, Ishizaka N, Taguchi Ji, Nagai R, Mori I, Tang SS, Ingelfinger JR, Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection. Hypertension. 2000 Mar; 35(3):800-6.
    View in: PubMed
  119. Grabowski EF, Carter CA, Ingelfinger JR, Tsukurov O, Conroy N, Abbott WM, Orkin RW. Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function. Pediatr Res. 1999 Dec; 46(6):742-7.
    View in: PubMed
  120. Zhang SL, Chen X, Filep JG, Tang SS, Ingelfinger JR, Chan JS. Insulin inhibits angiotensinogen gene expression via the mitogen-activated protein kinase pathway in rat kidney proximal tubular cells. Endocrinology. 1999 Nov; 140(11):5285-92.
    View in: PubMed
  121. Brem AS, Bina RB, Fitzpatrick C, King T, Tang SS, Ingelfinger JR. Glucocorticoid metabolism in proximal tubules modulates angiotensin II-induced electrolyte transport. Proc Soc Exp Biol Med. 1999 Jun; 221(2):111-7.
    View in: PubMed
  122. Ingelfinger JR, Woods LL. Cardiorenal destiny: the role of genes and environmental factors. Semin Nephrol. 1999 Mar; 19(2):201-10.
    View in: PubMed
  123. Christensen AM, Daouk GH, Norling LL, Catlin EA, Ingelfinger JR. Postnatal transient renal insufficiency in the feto-fetal transfusion syndrome. Pediatr Nephrol. 1999 Feb; 13(2):117-20.
    View in: PubMed
  124. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol. 1999 Feb; 276(2 Pt 2):F218-27.
    View in: PubMed
  125. Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JS. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int. 1999 Feb; 55(2):454-64.
    View in: PubMed
  126. Ingelfinger JR. Men's kidneys are from Mars and women's, from Venus. Kidney Int. 1999 Jan; 55(1):336-7.
    View in: PubMed
  127. Vallhonrat H, Swinford RD, Ingelfinger JR, Williams WW, Ryan DP, Tolkoff-Rubin N, Cosimi AB, Pascual M. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation. ASAIO J. 1999 Jan-Feb; 45(1):113-4.
    View in: PubMed
  128. Pascual M, Swinford RD, Ingelfinger JR, Williams WW, Cosimi AB, Tolkoff-Rubin N. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today. 1998 Nov; 19(11):514-9.
    View in: PubMed
  129. Elenberg E, Norling LL, Kleinman RE, Ingelfinger JR. Feeding problems in cystinosis. Pediatr Nephrol. 1998 Jun; 12(5):365-70.
    View in: PubMed
  130. Jung FF, Bachinsky DR, Tang SS, Zheng G, Diamant D, Haveran L, McCluskey RT, Ingelfinger JR. Immortalized rat proximal tubule cells produce membrane bound and soluble megalin. Kidney Int. 1998 Feb; 53(2):358-66.
    View in: PubMed
  131. Wang L, Lei C, Zhang SL, Roberts KD, Tang SS, Ingelfinger JR, Chan JS. Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells. Kidney Int. 1998 Feb; 53(2):287-95.
    View in: PubMed
  132. Norling LL, Smith TM, Ingelfinger JR. Stored renin isoforms in the developing rat kidney. Am J Hypertens. 1998 Feb; 11(2):213-8.
    View in: PubMed
  133. Agodoa L, Eknoyan G, Ingelfinger J, Keane W, Mauer M, Mitch W, Striker G, Wilcox C. Assessment of structure and function in progressive renal disease. Kidney Int Suppl. 1997 Dec; 63:S144-50.
    View in: PubMed
  134. Ingelfinger JR. When should essential hypertension in childhood be treated and how? Pediatr Nephrol. 1995 Oct; 9(5):552.
    View in: PubMed
  135. Gahl WA, Ingelfinger J, Mohan P, Bernardini I, Hyman PE, Tangerman A. Intravenous cysteamine therapy for nephropathic cystinosis. Pediatr Res. 1995 Oct; 38(4):579-84.
    View in: PubMed
  136. Amoah-Apraku B, Chandler LJ, Harrison JK, Tang SS, Ingelfinger JR, Guzman NJ. NF-kappa B and transcriptional control of renal epithelial-inducible nitric oxide synthase. Kidney Int. 1995 Sep; 48(3):674-82.
    View in: PubMed
  137. Guzman NJ, Fang MZ, Tang SS, Ingelfinger JR, Garg LC. Autocrine inhibition of Na+/K(+)-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest. 1995 May; 95(5):2083-8.
    View in: PubMed
  138. Tang SS, Jung F, Diamant D, Brown D, Bachinsky D, Hellman P, Ingelfinger JR. Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am J Physiol. 1995 Mar; 268(3 Pt 2):F435-46.
    View in: PubMed
  139. Jung FF, Kennefick TM, Ingelfinger JR, Vora JP, Anderson S. Down-regulation of the intrarenal renin-angiotensin system in the aging rat. J Am Soc Nephrol. 1995 Feb; 5(8):1573-80.
    View in: PubMed
  140. Amoah-Apraku B, Tang SS, Ingelfinger JR, Guzman NJ. Guanosine triphosphate cyclohydrolase I regulates nitric oxide synthesis in renal proximal tubules. J Am Soc Nephrol. 1995 Feb; 5(8):1630-3.
    View in: PubMed
  141. Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A. Analysis of hypertension in children post renal transplantation--a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol. 1994 Oct; 8(5):570-3.
    View in: PubMed
  142. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, Tang SS. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol. 1994 Aug; 267(2 Pt 2):H844-52.
    View in: PubMed
  143. Ubeda M, Matzilevich MM, Atucha NM, García-Estañ J, Quesada T, Tang SS, Ingelfinger JR. Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation. Hepatology. 1994 Jun; 19(6):1431-6.
    View in: PubMed
  144. Ingelfinger JR. Pediatric hypertension. Curr Opin Pediatr. 1994 Apr; 6(2):198-206.
    View in: PubMed
  145. Tang SS, Jung F, Diamant D, Ingelfinger J. Immortalized rat proximal tubule cell lines expressing components of the renin-angiotensin system. Exp Nephrol. 1994 Mar-Apr; 2(2):127.
    View in: PubMed
  146. Jung FF, Bouyounes B, Barrio R, Tang SS, Diamant D, Ingelfinger JR. Angiotensin converting enzyme in renal ontogeny: hypothesis for multiple roles. Pediatr Nephrol. 1993 Dec; 7(6):834-40.
    View in: PubMed
  147. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol. 1993 Oct; 265(4 Pt 2):F477-86.
    View in: PubMed
  148. Schunkert H, Tang SS, Litwin SE, Diamant D, Riegger G, Dzau VJ, Ingelfinger JR. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res. 1993 May; 27(5):731-5.
    View in: PubMed
  149. Jung FF, Ingelfinger JR. Hypertension in childhood and adolescence. Pediatr Rev. 1993 May; 14(5):169-79.
    View in: PubMed
  150. Brown MT, Cunningham MJ, Ingelfinger JR, Becker AN. Progressive sensorineural hearing loss in association with distal renal tubular acidosis. Arch Otolaryngol Head Neck Surg. 1993 Apr; 119(4):458-60.
    View in: PubMed
  151. Ingelfinger JR. Renovascular disease in children. Kidney Int. 1993 Feb; 43(2):493-505.
    View in: PubMed
  152. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993 Feb; 72(2):312-8.
    View in: PubMed
  153. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger JR, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation. 1993 Jan; 87(1):283-90.
    View in: PubMed
  154. Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation. 1992 Nov; 86(5):1566-74.
    View in: PubMed
  155. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol. 1992 Nov; 263(5 Pt 1):E863-9.
    View in: PubMed
  156. Ingelfinger JR, Jung F, Tang SS. Molecular biology techniques and their applicability to the study of diabetes and hypertension: the renin-angiotensin system as an example. J Am Soc Nephrol. 1992 Oct; 3(4 Suppl):S18-26.
    View in: PubMed
  157. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin SE, Talsness CE, Dzau VJ. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest. 1992 Oct; 90(4):1523-9.
    View in: PubMed
  158. Ingelfinger JR, Newburger JW. Spectrum of renal anomalies in patients with Williams syndrome. J Pediatr. 1991 Nov; 119(5):771-3.
    View in: PubMed
  159. Ingelfinger JR, Dzau VJ. Molecular biology of renal injury: emphasis on the role of the renin-angiotensin system. J Am Soc Nephrol. 1991 Aug; 2(2 Suppl 1):S9-20.
    View in: PubMed
  160. Schunkert H, Ingelfinger JR, Dzau VJ. Evolving concepts of the intrarenal renin-angiotensin system in health and disease: contributions of molecular biology. Ren Physiol Biochem. 1991 Jul-Oct; 14(4-5):146-54.
    View in: PubMed
  161. Sigmund CD, Jones CA, Jacob HJ, Ingelfinger J, Kim U, Gamble D, Dzau VJ, Gross KW. Pathophysiology of vascular smooth muscle in renin promoter-T-antigen transgenic mice. Am J Physiol. 1991 Feb; 260(2 Pt 2):F249-57.
    View in: PubMed
  162. Sigmund CD, Okuyama K, Ingelfinger J, Jones CA, Mullins JJ, Kane C, Kim U, Wu CZ, Kenny L, Rustum Y, et al. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem. 1990 Nov 15; 265(32):19916-22.
    View in: PubMed
  163. Ingelfinger JR, Schunkert H, Ellison KE, Pivor M, Zuo WM, Pratt R, Dzau VJ. Intrarenal angiotensinogen: localization and regulation. Pediatr Nephrol. 1990 Jul; 4(4):424-8.
    View in: PubMed
  164. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest. 1990 Feb; 85(2):417-23.
    View in: PubMed
  165. Hirschman GH, Striker GE, Vernier RL, Chesney RW, Holliday MA, Ingelfinger JR, Kopple JD, Rich SS, Williams GW. Growth Failure in Children with Renal Diseases Study: an overview from the National Institutes of Health and the Advisory Committee. J Pediatr. 1990 Feb; 116(2):S8-10.
    View in: PubMed
  166. Kwiterovich PO, Ingelfinger J, Leibel RL, Lauer RM, Olson C. Panel discussion: early nutrition in adult disease prevention. Bull N Y Acad Med. 1989 Dec; 65(10):1154-60.
    View in: PubMed
  167. Ingelfinger JR. Nutritional aspects of pediatric hypertension. Bull N Y Acad Med. 1989 Dec; 65(10):1109-20; discussion 1154-60.
    View in: PubMed
  168. Rudd MA, Plavin S, Hirsch AT, Ingelfinger JR, Dzau VJ. Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation. Circ Res. 1989 Nov; 65(5):1324-9.
    View in: PubMed
  169. Dzau VJ, Ingelfinger JR. Molecular biology and pathophysiology of the intrarenal renin-angiotensin system. J Hypertens Suppl. 1989 Sep; 7(7):S3-8.
    View in: PubMed
  170. Ingelfinger JR. Noninvasive evaluation of pediatric hypertension. Pediatr Ann. 1989 Sep; 18(9):551-2, 554-5, 558-60.
    View in: PubMed
  171. Mishler EG, Clark JA, Ingelfinger J, Simon MP. The language of attentive patient care: a comparison of two medical interviews. J Gen Intern Med. 1989 Jul-Aug; 4(4):325-35.
    View in: PubMed
  172. Dzau VJ, Paul M, Nakamura N, Pratt RE, Ingelfinger JR. Role of molecular biology in hypertension research. State of the Art lecture. Hypertension. 1989 Jun; 13(6 Pt 2):731-40.
    View in: PubMed
  173. Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ. Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest. 1989 Jun; 83(6):1941-5.
    View in: PubMed
  174. Ingelfinger JR, Pratt RE, Roth TP, Dzau VJ. Processing of one-chain to two-chain renin in the mouse submandibular gland is influenced by androgen. Pediatr Res. 1989 Apr; 25(4):332-5.
    View in: PubMed
  175. Pratt RE, Zou WM, Naftilan AJ, Ingelfinger JR, Dzau VJ. Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat. Am J Physiol. 1989 Mar; 256(3 Pt 2):F469-74.
    View in: PubMed
  176. Ingelfinger JR, Pratt RE, Dzau VJ. Regulation of extra-renal renin during ontogeny. Endocrinology. 1988 Mar; 122(3):782-6.
    View in: PubMed
  177. Colan SD, Sanders SP, Ingelfinger JR, Harmon W. Left ventricular mechanics and contractile state in children and young adults with end-stage renal disease: effect of dialysis and renal transplantation. J Am Coll Cardiol. 1987 Nov; 10(5):1085-94.
    View in: PubMed
  178. Dzau VJ, Ellison KE, Brody T, Ingelfinger J, Pratt RE. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology. 1987 Jun; 120(6):2334-8.
    View in: PubMed
  179. Dzau VJ, Brody T, Ellison KE, Pratt RE, Ingelfinger JR. Tissue-specific regulation of renin expression in the mouse. Hypertension. 1987 Jun; 9(6 Pt 2):III36-41.
    View in: PubMed
  180. Ingelfinger JR, Pratt RE, Ellison K, Dzau VJ. Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest. 1986 Nov; 78(5):1311-5.
    View in: PubMed
  181. Dzau VJ, Ingelfinger J, Pratt RE, Ellison KE. Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension. 1986 Jun; 8(6):544-8.
    View in: PubMed
  182. Ingelfinger JR, Pratt RE, Ellison KE, Roth TP, Dzau VJ. Multiple sites of regulation of mouse renin expression in ontogeny. Clin Exp Hypertens A. 1986; 8(4-5):687-94.
    View in: PubMed
  183. Dzau VJ, Ingelfinger JR, Pratt RE. Regulation of tissue renin and angiotensin gene expressions. J Cardiovasc Pharmacol. 1986; 8 Suppl 10:S11-6.
    View in: PubMed
  184. Rosen PR, Treves S, Ingelfinger J. Hypertension in children. Increased efficacy of technetium Tc 99m succimer in screening for renal disease. Am J Dis Child. 1985 Feb; 139(2):173-7.
    View in: PubMed
  185. Ingelfinger JR. Sodium and blood pressure in infancy. JAMA. 1983 Jul 15; 250(3):389-90.
    View in: PubMed
  186. Avner ED, Ingelfinger JR, Herrin JT, Link DA, Marcus E, Tolkoff-Rubin NE, Russell-Getz L, Rubin RH. Single-dose amoxicillin therapy of uncomplicated pediatric urinary tract infections. J Pediatr. 1983 Apr; 102(4):623-7.
    View in: PubMed
  187. Krensky AM, Ingelfinger JR, Grupe WE, Rosen S. Hemolytic uremic syndrome and crescentic glomerulonephritis complicating childhood nephrosis. Clin Nephrol. 1983 Feb; 19(2):99-106.
    View in: PubMed
  188. Harmon WE, Parkman R, Lavin PT, Grupe WE, Ingelfinger JR, Yunis EJ, Levey RH. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J Immunol. 1982 Oct; 129(4):1573-7.
    View in: PubMed
  189. Krensky AM, Ingelfinger JR, Grupe WE. Peritonitis in childhood nephrotic syndrome: 1970-1980. Am J Dis Child. 1982 Aug; 136(8):732-6.
    View in: PubMed
  190. Harmon WE, Lavin PT, Parkman R, Ingelfinger JR, Grupe WE, Levey RH. Correlation of early acute rejection episodes with long-term renal transplant outcome. Transplantation. 1982 Jun; 33(6):648-9.
    View in: PubMed
  191. Ingelfinger JR. Pediatric hypertension. Major Probl Clin Pediatr. 1982; 24:1-297.
    View in: PubMed
  192. Krensky AM, Harmon WE, Ingelfinger JR, Kirkpatrick JA, Grupe WE. Elevated nephrogenous cyclic adenosine monophosphate to monitor early renal osteodystrophy. Clin Nephrol. 1981 Nov; 16(5):245-50.
    View in: PubMed
  193. Ingelfinger JR, Grupe WE, Harmon WE, Fernbach SK, Levey RH. Growth acceleration following renal transplantation in children less than 7 years of age. Pediatrics. 1981 Aug; 68(2):255-9.
    View in: PubMed
  194. Caldicott WJ, Ingelfinger JR. The influence of increased renal mass on cardiovascular function in immature dogs. Pediatr Res. 1981 Jun; 15(6):935-9.
    View in: PubMed
  195. Ingelfinger JR, Grupe WE, Levey RH. Post-transplant hypertension in the absence of rejection or recurrent disease. Clin Nephrol. 1981 May; 15(5):236-9.
    View in: PubMed
  196. Avner ED, Harmon WE, Grupe WE, Ingelfinger JR, Eraklis AJ, Levey RH. Mortality of chronic hemodialysis and renal transplantation in pediatric end-stage renal disease. Pediatrics. 1981 Mar; 67(3):412-6.
    View in: PubMed
  197. Ingelfinger JR, Teele R, Treves S, Levey RH. Renal growth after transplantation: infant kidney received by adolescent. Clin Nephrol. 1981 Jan; 15(1):28-32.
    View in: PubMed
  198. Ingelfinger JR. Nephrotic syndrome in the second decade of life. J Adolesc Health Care. 1980 Sep; 1(1):42-5.
    View in: PubMed
  199. Williams SA, Makker SP, Ingelfinger JR, Grupe WE. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med. 1980 Apr 24; 302(17):929-33.
    View in: PubMed
  200. Robson AM, Mor J, Root ER, Jager BV, Shankel SW, Ingelfinger JR, Kienstra RA, Bricker NS. Mechanism of proteinuria in nonglomerular renal disease. Kidney Int. 1979 Sep; 16(3):416-29.
    View in: PubMed
  201. Avner ED, Harmon WE, Ingelfinger JR, Levey RH, Grupe WE. Mortality of chronic hemodialysis comparable to that of renal transplantation in pediatric end-stage renal disease. Proc Clin Dial Transplant Forum. 1979; 9:1-4.
    View in: PubMed
  202. Levey RH, Ingelfinger J, Grupe WE, Toper M, Eraklis AJ. Unique surgical and immunologic features of renal transplantation in children. J Pediatr Surg. 1978 Dec; 13(6D):576-80.
    View in: PubMed
  203. Williams SA, Ingelfinger JR, Colodny A. Abdominal enlargement. A parent may be the first to know. Clin Pediatr (Phila). 1977 Dec; 16(12):1128-31.
    View in: PubMed
  204. Ingelfinger JR, McCluskey RT, Schneeberger EE, Grupe WE. Necrotizing arteritis in acute poststreptococcal glomerulonephritis: report of a recovered case. J Pediatr. 1977 Aug; 91(2):228-32.
    View in: PubMed
  205. Ingelfinger JR, Davis AE, Grupe WE. Frequency and etiology of gross hematuria in a general pediatric setting. Pediatrics. 1977 Apr; 59(4):557-61.
    View in: PubMed
  206. Ingelfinger JR, Grupe WE, Topor M, Levey RH. Warts in a pediatric renal transplant population. Dermatologica. 1977; 155(1):7-12.
    View in: PubMed
  207. Alkjaersig NK, Fletcher AP, Lewis ML, Cole BR, Ingelfinger JR, Robson AM. Pathophysiological response of the blood coagulation system in acute glomerulonephritis. Kidney Int. 1976 Oct; 10(4):319-28.
    View in: PubMed
  208. Grupe WE, Makker SP, Ingelfinger JR. Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med. 1976 Sep 30; 295(14):746-9.
    View in: PubMed
  209. Saldanha LF, Hurst KS, Amend WJ, Lazarus JM, Lowrie EG, Ingelfinger J, Grupe W, Levey R. Hyperlipidemia after renal transplantation in children. Am J Dis Child. 1976 Sep; 130(9):951-3.
    View in: PubMed
  210. Robson AM, Giangiacomo J, Kienstra RA, Naqvi ST, Ingelfinger JR. Normal glomerular permeability and its modification by minimal change nephrotic syndrmone. J Clin Invest. 1974 Nov; 54(5):1190-9.
    View in: PubMed
  211. Cole BR, Giangiacomo J, Ingelfinger JR, Robson AM. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate. N Engl J Med. 1972 Nov 30; 287(22):1109-14.
    View in: PubMed
  212. Robson AM, Tateishi S, Ingelfinger JR, Strominger DB, Klahr S. Renal function in patients with cystic fibrosis. J Pediatr. 1971 Jul; 79(1):42-50.
    View in: PubMed
  213. Ingelfinger JR, Kissane JM, Robson AM. Glomerulomegaly in a patient with cyanotic congenital heart disease. Am J Dis Child. 1970 Jul; 120(1):69-71.
    View in: PubMed
  214. Ingelfinger JR, Hays RM. Evidence that chlorpropamide and vasopressin share a common site of action. J Clin Endocrinol Metab. 1969 May; 29(5):738-40.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Ingelfinger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_